Award
NIH Reporter #1R03DK149488-01
Shifting Acute Severe Ulcerative Colitis Away from the Hospital: A Pilot Randomized Trial of Outpatient ASUC Management
Recipient
University of Michigan at Ann Arbor
Award Amount
$117,000.00
Ceiling
$117,000.00
Awarded
August 11, 2026
Identifier
1R03DK149488-01
This NIH-funded pilot study tests a novel outpatient treatment for acute severe ulcerative colitis using Janus kinase inhibitors, focusing on safety and feasibility to reduce hospital stays and healthcare costs.
Description
A pilot randomized clinical trial to evaluate oral Janus kinase inhibitor therapy for outpatient treatment of acute severe ulcerative colitis (ASUC), aiming to establish feasibility, safety, and optimal endpoints for outpatient management to reduce hospitalizations and improve patient-centered care.